Meta-analysis comparing incidence of grade 3-4 neutropenia with ALK inhibitors and chemotherapy in patients with non-small-cell lung cancer.

MLA

Rapoport, Bernardo, et al. “Meta-Analysis Comparing Incidence of Grade 3-4 Neutropenia with ALK Inhibitors and Chemotherapy in Patients with Non-Small-Cell Lung Cancer.” Future Oncology, vol. 15, no. 18, June 2019, pp. 2163–74. EBSCOhost, https://doi.org/10.2217/fon-2018-0863.

APA

Rapoport, B., Arani, R. B., Mathieson, N., & Krendyukov, A. (2019). Meta-analysis comparing incidence of grade 3-4 neutropenia with ALK inhibitors and chemotherapy in patients with non-small-cell lung cancer. Future Oncology, 15(18), 2163–2174. https://doi.org/10.2217/fon-2018-0863

Chicago

Rapoport, Bernardo, Ramin B Arani, Nicola Mathieson, and Andriy Krendyukov. 2019. “Meta-Analysis Comparing Incidence of Grade 3-4 Neutropenia with ALK Inhibitors and Chemotherapy in Patients with Non-Small-Cell Lung Cancer.” Future Oncology 15 (18): 2163–74. doi:10.2217/fon-2018-0863.